The effects of intra-articular Sodium Hyaluronate Injection after Arthroscopic Débridement for Osteoarthritis of the Knee evaluated by pain and physical scales: A Prospective, Randomized, Controlled Study

Hacettepe University0 个研究点目标入组 80 人开始时间: 2008年4月14日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•age between 40-65 years, symptomatic primary knee OA according to American College of Rheumatology criteria with a Kellgren-Lawrence (K-L) severity grade of level II or III as determined radiographically at screening.

•Patients who refused to provide the written informed consent for taking part in the study, agreed to follow study procedures and attend all study visits.
•Patients with previously known bleeding diathesis or coagulation disorder,
•Patients who have any form of contraindication for an arthroscopy procedure,
•Patients with known allergies against chicken or chicken products for intra-articular sodium hyaluronate injection,
•Patients with secondary arthritis, like rheumatoid arthritis or suspected to have any other form of an inflammatory arthritis,
•Patients in whom microfracture” technique was used during AD,
•Patients with major frontal plane deformities,
•Patients with patellar disorder or quadriceps mechanism disorders,
•Patients with advanced level of mental handicap preventing them from fulfilling the study requirements.

发起方